Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, Mogensen J, McKenna WJ.

Eur Heart J. 2006 Aug;27(16):1933-41. Epub 2006 Jun 5.

PMID:
16754630
2.

Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.

Efthimiadis GK, Parcharidou DG, Giannakoulas G, Pagourelias ED, Charalampidis P, Savvopoulos G, Ziakas A, Karvounis H, Styliadis IH, Parcharidis GE.

Am J Cardiol. 2009 Sep 1;104(5):695-9. doi: 10.1016/j.amjcard.2009.04.039. Epub 2009 Jun 24.

PMID:
19699347
3.

Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

Gimeno JR, Tomé-Esteban M, Lofiego C, Hurtado J, Pantazis A, Mist B, Lambiase P, McKenna WJ, Elliott PM.

Eur Heart J. 2009 Nov;30(21):2599-605. doi: 10.1093/eurheartj/ehp327. Epub 2009 Aug 17.

PMID:
19689975
4.

Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.

McLeod CJ, Ommen SR, Ackerman MJ, Weivoda PL, Shen WK, Dearani JA, Schaff HV, Tajik AJ, Gersh BJ.

Eur Heart J. 2007 Nov;28(21):2583-8. Epub 2007 May 4.

PMID:
17483110
5.

Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ.

J Am Coll Cardiol. 2003 Sep 3;42(5):873-9.

6.

Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.

Shah JS, Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A, Ward D, Kohli SK, Page SP, Demetrescu C, Sevdalis E, Keren A, Pellerin D, McKenna WJ, Elliott PM.

Heart. 2008 Oct;94(10):1288-94. Epub 2007 Nov 21.

PMID:
18032461
7.
8.

[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].

Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.

Z Kardiol. 2000;89 Suppl 3:194-205. German.

PMID:
10810803
10.

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.

Circ Heart Fail. 2010 Jan;3(1):51-8. doi: 10.1161/CIRCHEARTFAILURE.109.854026. Epub 2009 Oct 22.

11.

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ.

J Am Coll Cardiol. 2000 Dec;36(7):2212-8.

14.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

15.

Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.

Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.

Eur Heart J. 2007 Jul;28(14):1746-9. Epub 2007 Feb 5.

PMID:
17283003
16.

Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.

J Am Coll Cardiol. 2005 Mar 1;45(5):697-704.

17.

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L.

Pacing Clin Electrophysiol. 2003 Sep;26(9):1887-96.

PMID:
12930505
18.

[Current aspects of defibrillator therapy in congestive heart failure].

Trappe HJ, Meine M, Pfitzner P, Voigt B, Weismüller P.

Z Kardiol. 2001;90 Suppl 1:28-34. German.

PMID:
11261337
19.

Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.

Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.

Am J Cardiol. 2009 Jul 1;104(1):128-32. doi: 10.1016/j.amjcard.2009.02.056. Epub 2009 May 4.

PMID:
19576333
20.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314

Supplemental Content

Support Center